Advocacy
Quality of Care Standards in Inflammatory Bowel Diseases
Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn’s and Colitis Organisation [ECCO] Position Paper
February, 2020
The Future of Biosimilars
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
February, 2020
The Socioeconomic Impact of Living With Ulcerative Colitis
43 The Socioeconomic Impact of Living With Ulcerative Colitis: A Burden of Illness Study
October, 2019
The living with Ulcerative Colitis (UC), identifying the socioeconomic burden in Europe (LUCID) study was a descriptive, retrospective, cross-sectional, European, multi-site, bottom-up Burden of Illness research study carried out by HCD Economics and the University of Chester in partnership with Crohn's and Colitis UK.
The Impact of Ulcerative Colitis on Quality of Life and Productivity Across Europe
744 The Impact of Ulcerative Colitis on Quality of Life and Productivity Across Europe: A Burden of Illness Study
October, 2019
Changes in inflammatory bowel disease patients’ perspectives on biosimilars
Changes in inflammatory bowel disease patients’ perspectives on biosimilars: A follow-up survey
October, 2019
The aim of this survey was to find out whether the perspectives of patients with inflammatory bowel disease concerning biosimilars have changed since the publication of our last survey carried out in 2014–2015.
Innovative medicines - Mapping project
Innovative medicines - EU mapping project
Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease
Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication Strategies
October, 2018
Preparing for the incoming wave of biosimilars in oncology
Preparing for the incoming wave of biosimilars in oncology
September, 2018
Survey on couple with IBD and their offspring
IBD and parenthood - Survey on couples with IBD and their offspring